Blue Wave: How Much Runway the 2025 Fundraises Really Bought
Blue Wave's 2025 fundraises look larger in the headline than in the cash balance: NIS 2.6 million of gross equity raising turned into NIS 2.081 million of net financing cash flow, year-end cash fell to just NIS 19 thousand, and the March 2026 option extension opened only a limited and conditional ceiling.
The main article already showed that Blue Wave returned to positive equity in 2025, but liquidity did not follow. This continuation isolates the more practical question: how much time the 2025 fundraises actually bought, how much of the headline amount turned into real cash, and whether the March 31, 2026 option extension materially changed the oxygen line.
Three points frame the answer immediately:
- NIS 2.6 million in the headline did not become NIS 2.6 million in the bank. The 2025 capital raises totaled NIS 2.595 million gross, but net financing cash flow was only NIS 2.081 million.
- Even after the post-balance receivable, the cash cushion stayed extremely thin. Year-end cash was NIS 19 thousand, and another NIS 452 thousand was recorded as a receivable from share allotments that was collected only after the balance-sheet date. Near the approval date of the report, cash was already down to about NIS 9 thousand.
- The option extension creates a possible ceiling, not incoming cash. Even full exercise of the 240,909 investor options extended to September 6, 2026 would add only about NIS 439 thousand gross, and only if all holders actually exercise.
What The 2025 Fundraises Really Bought
When the active bottleneck is funding, the right framing is all-in cash flexibility, not just operating burn. The question is how much cash remained after the real uses of cash needed to keep the story alive, especially the payment to Copter.
That bridge is the whole story. Blue Wave entered 2025 with NIS 398 thousand of cash, generated NIS 2.081 million of net financing cash flow, burned NIS 1.67 million in operating activity, and used another NIS 790 thousand to complete Copter's second milestone. The result was only NIS 19 thousand of cash at year-end.
Put differently, the 2025 fundraises did not build a cushion. They funded the year itself. Even on a narrower reading that strips out the Copter payment and looks only at operating cash burn, the annual burn rate was still NIS 1.67 million, or roughly NIS 139 thousand per month. On the all-in reading, including the Copter payment, cash use was roughly NIS 205 thousand per month. That is the gap between "the company managed to raise money" and "the company bought runway."
There is another layer here. The purchase model attached to the Copter transaction does not describe an asset that is about to fund itself. In Annex B, Copter still shows negative FCF of NIS 666 thousand in 2025 and negative FCF of NIS 763 thousand in 2026, turning positive only in 2027. That makes it hard to argue that the 2025 fundraises merely had to bridge the company until the asset began carrying itself. Even the asset behind the thesis is still modeled as cash-consuming.
The Fundraising Headline Is Bigger Than The Cash That Stayed
The cleanest way to understand the cost of 2025 is to line up the cash raised against the securities that went out to shareholders.
| Round | Gross cash | Immediate shares issued | Options granted | What else went out to shareholders |
|---|---|---|---|---|
| April 2025 | NIS 770 thousand | 440,909 | 240,909 | Exercise price of NIS 1.20 for 90,909 options and NIS 2.20 for 150,000 options |
| June 2025 | NIS 590 thousand | 478,571 | 205,000 | Exercise price of NIS 2.00 for 140,000 options and NIS 2.40 for 65,000 options |
| December 2025 | NIS 1.235 million | 709,177 | 631,500 | An additional 171,217 shares were issued to two advisors instead of NIS 264,886 of cash fees |
| Non-cash dilution | 0 | 57,209 | 0 | Shares issued under a settlement arrangement |
The three cash rounds together produced a gross headline of NIS 2.595 million, but the cash flow statement shows only NIS 2.081 million of net financing inflow. The gap is not cosmetic. It shows that between the fundraising headline and the money that actually landed in cash sit both issuance costs and collection timing.
That is exactly what the NIS 452 thousand receivable from share allotments means. It was still booked as a receivable at year-end and was transferred only after the balance-sheet date. So the NIS 19 thousand of year-end cash is not the whole picture, but even the fuller picture is still tight: adding that receivable gets to only about NIS 471 thousand. Then comes the second hit. The board report says that near the approval date of the financial statements, the cash balance was already down to about NIS 9 thousand. In other words, even the oxygen that arrived after the balance sheet did not remain in the bank for long.
That is the analytical point. At Blue Wave, dilution is not a side effect of the growth story. It is the company's operating mechanism. Shares leave the company faster than cash stays inside it.
The Extended Options Buy A Theoretical Ceiling, Not A Solution
At first glance, the March 31, 2026 filing sounds like financing news: the board extended by six months, until September 6, 2026, the exercise period of 240,909 investor options granted in the April 2025 round. But the same notice also says that no other term of the options or their attached rights changed. That matters, because an extension does not generate cash. It only keeps the window open for a possible exercise.
Full exercise of all 240,909 options would bring in about NIS 439.1 thousand gross: about NIS 109.1 thousand from the 90,909 options with a NIS 1.20 strike, and another NIS 330 thousand from the 150,000 options with a NIS 2.20 strike.
That chart shows why the extension does not change the rules of the game. Based on a share price of NIS 1.794 on April 6, 2026, only the NIS 1.20 strike tranche was in the money. The NIS 2.20 tranche was still out of the money. So even on a generous read, the practical ceiling looks much closer to NIS 109 thousand than to NIS 439 thousand.
And even the generous ceiling does not solve much. Against the 2025 operating cash burn, NIS 439 thousand is only about 3.1 months of activity. On the all-in reading that also includes the Copter payment, it is closer to 2.1 months. If one looks only at the tranche that was already in the money in early April 2026, it is less than one month. The extension may delay the moment of truth a little, but it does not replace a raise.
Why Capital Markets Still Remain The Active Bottleneck
This is where the practical constraint becomes impossible to ignore. As of December 31, 2025 and as of the report date, the company had no bank or non-bank loans and no credit facilities. On paper that may look clean. In practice it means Blue Wave has no credit backstop. Without internal cash generation, almost the entire survival path runs through equity.
That equity path is not fully open either. The company's shares have been on the preservation list since July 17, 2023 because the company failed to meet the minimum public-holdings value requirement. At the same time, the shelf prospectus was extended in March 2025 until February 23, 2026, but even during that extension any shelf-offering report would have required a permit from the Israel Securities Authority because of the ongoing shell-company review and the change in the company's line of business. By the report date, the company already had no shelf prospectus in force.
That is not a technical footnote. If there is no bank credit, no facilities, a preservation-list status, and no effective shelf prospectus, then the capital markets are not available to the company as a wide and flexible funding channel. They are available mostly through private placements, options, and point solutions. That is why even an extension of 240,909 investor options becomes a financing event worth isolating on its own.
Bottom Line
The 2025 fundraises bought Blue Wave time, but not much of it. They turned a gross headline of NIS 2.595 million into NIS 2.081 million of net financing cash flow, ended the year with just NIS 19 thousand of cash, and left another NIS 452 thousand to arrive only after the balance-sheet date. Even that amount did not stay long, because near the approval date of the report the cash balance was already down to about NIS 9 thousand.
That is the core of the story. Blue Wave did not finish 2025 with new financial flexibility. It finished with another equity round that bought a short bridge. The March 2026 option extension does not change that. In the best case it can add roughly NIS 439 thousand gross. In the more practical case, based on the early April 2026 share price, only a small part of that amount was already in the money.
So the Blue Wave discussion in 2026 remains a discussion about access to capital, not balance-sheet comfort. As long as Copter itself still looks, in the attached model, like an asset that requires funding through 2026, and as long as the company remains dependent mainly on private placements under clear market-access constraints, dilution is not only the price of growth. It is the condition for continuing the activity.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.